D-Index & Metrics Best Publications
Microbiology
France
2023

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 82 Citations 30,330 538 World Ranking 613 National Ranking 31
Medicine D-index 84 Citations 39,566 575 World Ranking 9809 National Ranking 287

Research.com Recognitions

Awards & Achievements

2023 - Research.com Microbiology in France Leader Award

Overview

What is he best known for?

The fields of study he is best known for:

  • Bacteria
  • Antibiotics
  • Internal medicine

Jean-Marc Rolain mainly focuses on Microbiology, Virology, Antibiotics, Antibiotic resistance and Polymerase chain reaction. His Microbiology research includes elements of Acinetobacter baumannii and Bacteria. He combines subjects such as Chloroquine, Coronavirus and Pneumonia with his study of Virology.

His research in Antibiotics intersects with topics in Pseudomonas aeruginosa and Teicoplanin. His work carried out in the field of Antibiotic resistance brings together such families of science as Biotechnology, Antimicrobial, Outbreak and Klebsiella pneumoniae. His studies in Polymerase chain reaction integrate themes in fields like rpoB and Staphylococcus aureus.

His most cited work include:

  • Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. (2594 citations)
  • Ongoing Revolution in Bacteriology: Routine Identification of Bacteria by Matrix-Assisted Laser Desorption Ionization Time-of-Flight Mass Spectrometry (1393 citations)
  • ARG-ANNOT, a New Bioinformatic Tool To Discover Antibiotic Resistance Genes in Bacterial Genomes (651 citations)

What are the main themes of his work throughout his whole career to date?

Microbiology, Virology, Antibiotics, Gene and Antibiotic resistance are his primary areas of study. His study of Colistin is a part of Microbiology. Jean-Marc Rolain has researched Colistin in several fields, including MCR-1, Enterobacteriaceae and Colistin resistance.

His research on Virology often connects related areas such as Polymerase chain reaction. In his study, Bacterial genetics is strongly linked to Drug resistance, which falls under the umbrella field of Antibiotic resistance. His Bartonella study combines topics in areas such as Bartonella henselae and Bartonella quintana.

He most often published in these fields:

  • Microbiology (54.90%)
  • Virology (19.93%)
  • Antibiotics (16.22%)

What were the highlights of his more recent work (between 2018-2021)?

  • Microbiology (54.90%)
  • Antibiotic resistance (15.03%)
  • Antibiotics (16.22%)

In recent papers he was focusing on the following fields of study:

Jean-Marc Rolain mainly investigates Microbiology, Antibiotic resistance, Antibiotics, Colistin and Gene. His Microbiology research integrates issues from MCR-1, Escherichia coli, Enterobacteriaceae, Colistin resistance and Klebsiella pneumoniae. His Antibiotic resistance study incorporates themes from One Health, Internal medicine and Multiple drug resistance.

The Antibiotics study combines topics in areas such as Veterinary medicine and Acinetobacter baumannii. In Colistin, Jean-Marc Rolain works on issues like Carbapenem, which are connected to Tigecycline. While the research belongs to areas of Chloroquine, Jean-Marc Rolain spends his time largely on the problem of Coronavirus Infections, intersecting his research to questions surrounding Coronavirus, Virology and Pneumonia.

Between 2018 and 2021, his most popular works were:

  • Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. (2594 citations)
  • New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? (491 citations)
  • Chloroquine and Hydroxychloroquine as Available Weapons to Fight COVID-19 (465 citations)

In his most recent research, the most cited papers focused on:

  • Bacteria
  • Antibiotics
  • Internal medicine

The scientist’s investigation covers issues in Microbiology, Hydroxychloroquine, Coronavirus, Antibiotics and Internal medicine. The various areas that Jean-Marc Rolain examines in his Microbiology study include MCR-1, Colistin resistance and Escherichia coli. He has included themes like Virus, Chloroquine and Azithromycin in his Hydroxychloroquine study.

Jean-Marc Rolain combines subjects such as Pandemic, Pneumonia and Virology with his study of Coronavirus. His work in Virology tackles topics such as Betacoronavirus which are related to areas like Severe acute respiratory syndrome coronavirus 2. His work in Internal medicine covers topics such as Viral load which are related to areas like Regimen, Retrospective cohort study and Case fatality rate.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.

Philippe Gautret;Jean Christophe Lagier;Philippe Parola;Van Thuan Hoang.
International Journal of Antimicrobial Agents (2020)

5474 Citations

Ongoing Revolution in Bacteriology: Routine Identification of Bacteria by Matrix-Assisted Laser Desorption Ionization Time-of-Flight Mass Spectrometry

Piseth Seng;Michel Drancourt;Freédésrique Gouriet;Bernard La Scola.
Clinical Infectious Diseases (2009)

2006 Citations

New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?

Christian A. Devaux;Christian A. Devaux;Jean Marc Rolain;Philippe Colson;Didier Raoult.
International Journal of Antimicrobial Agents (2020)

1157 Citations

Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria

Abiola Olumuyiwa Olaitan;Serge Morand;Jean-Marc Rolain.
Frontiers in Microbiology (2014)

1093 Citations

Chloroquine and Hydroxychloroquine as Available Weapons to Fight COVID-19

Philippe Colson;Jean-Marc Rolain;Jean-Christophe Lagier;Philippe Brouqui.
International Journal of Antimicrobial Agents (2020)

996 Citations

ARG-ANNOT, a New Bioinformatic Tool To Discover Antibiotic Resistance Genes in Bacterial Genomes

Sushim Kumar Gupta;Babu Roshan Padmanabhan;Seydina M. Diene;Rafael Lopez-Rojas.
Antimicrobial Agents and Chemotherapy (2014)

991 Citations

The global threat of antimicrobial resistance: science for intervention

Ignasi Roca;Murat Akova;F. Baquero;Jean Carlet.
new microbes and new infections (2015)

968 Citations

Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study.

Philippe Gautret;Jean Christophe Lagier;Philippe Parola;Van Thuan Hoang.
Travel Medicine and Infectious Disease (2020)

796 Citations

Culture of previously uncultured members of the human gut microbiota by culturomics

Jean-Christophe Lagier;Saber Khelaifia;Maryam Tidjani Alou;Sokhna Ndongo.
Nature microbiology (2016)

715 Citations

Recommendations for Treatment of Human Infections Caused by Bartonella Species

J. M. Rolain;P. Brouqui;J. E. Koehler;C. Maguina.
Antimicrobial Agents and Chemotherapy (2004)

567 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Jean-Marc Rolain

Didier Raoult

Didier Raoult

Aix-Marseille University

Publications: 1179

Pierre-Edouard Fournier

Pierre-Edouard Fournier

Aix-Marseille University

Publications: 342

Jean-Christophe Lagier

Jean-Christophe Lagier

Aix-Marseille University

Publications: 154

Stuart D. Blacksell

Stuart D. Blacksell

Mahidol University

Publications: 103

Paul N. Newton

Paul N. Newton

University of Oxford

Publications: 101

Michel Drancourt

Michel Drancourt

Aix-Marseille University

Publications: 89

Nicholas P. J. Day

Nicholas P. J. Day

University of Oxford

Publications: 82

Bernard La Scola

Bernard La Scola

Aix-Marseille University

Publications: 71

Philippe Parola

Philippe Parola

Grenoble Alpes University

Publications: 68

Edward B. Breitschwerdt

Edward B. Breitschwerdt

North Carolina State University

Publications: 66

Florence Fenollar

Florence Fenollar

Centre national de la recherche scientifique, CNRS

Publications: 64

Bruno B Chomel

Bruno B Chomel

University of California, Davis

Publications: 56

Michael Kosoy

Michael Kosoy

Centers for Disease Control and Prevention

Publications: 50

Catherine Robert

Catherine Robert

Aix-Marseille University

Publications: 50

Patrice Nordmann

Patrice Nordmann

University of Fribourg

Publications: 49

Laurent Poirel

Laurent Poirel

University of Fribourg

Publications: 48

Trending Scientists

Chen-Khong Tham

Chen-Khong Tham

National University of Singapore

Aad van der Vaart

Aad van der Vaart

Leiden University

Kenton O'Hara

Kenton O'Hara

Microsoft (United States)

Toshikazu Ushijima

Toshikazu Ushijima

National Cancer Centre

Scott D. Peacor

Scott D. Peacor

Michigan State University

Enrique Cadenas

Enrique Cadenas

University of Southern California

Alejandro H. Buschmann

Alejandro H. Buschmann

University of Los Lagos

Christian Herrmann

Christian Herrmann

Ruhr University Bochum

Åsa Ljungh

Åsa Ljungh

Lund University

Marit-Solveig Seidenkrantz

Marit-Solveig Seidenkrantz

Aarhus University

John V. Martonchik

John V. Martonchik

Jet Propulsion Lab

Douglas H. Lowenthal

Douglas H. Lowenthal

Desert Research Institute

Ian Milsom

Ian Milsom

University of Gothenburg

Terje Andreas Eikemo

Terje Andreas Eikemo

Norwegian University of Science and Technology

John M. Benson

John M. Benson

Harvard University

Časlav Brukner

Časlav Brukner

Austrian Academy of Sciences

Something went wrong. Please try again later.